Neurodegenerative Diseases
The aim of this work funded by Aligning Science Across Parkinson’s (ASAP), in collaboration with Dr. Alessandro Sette, is to
Lindestam Arlehamn Lab
Cecilia Lindestam Arlehamn,
Ph.D.
Assistant Professor
My laboratory is focused on understanding T cell immune responses to Mycobacterium tuberculosis and other infections, as well as self-antigens
Six LJI scientists named “Highly Cited Researchers”
The international recognition reflects how LJI research is valued by scientific peers
Inside the labs of three leading San Diego scientists
LA JOLLA—Studying the immune system means venturing into uncharted territory, leading explorations of the countless immune cells and genetic players
LJI scientists receive $3.5 million to investigate role of immune cells in Parkinson’s disease
LA JOLLA—Scientists at the La Jolla Institute for Immunology (LJI) have received $3.5 million as part of a team award
Parkinson’s
The lab investigates T cell reactivity and disease progression in Parkinson’s disease. Findings suggest immune cells are responsible for disease
Sette Lab
Alessandro Sette,
Dr.Biol.Sci.
Professor
Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research
Alessandro Sette, Dr. Biol. Sci., defines in chemical terms the specific structures (epitopes) that the immune system recognizes and uses this knowledge to measure and understand immune responses.
LJI Scientists Link Immune Cells to Parkinson’s Disease Onset
LA JOLLA—A new study co-led by scientists at the La Jolla Institute for Immunology (LJI) adds increasing evidence that Parkinson’s
Q&A with Alessandro Sette, Dr. Biol. Sci.
Raised in Rome, Italy, in a family of lawyers, Dr. Sette started his science career as a young boy in
Groundbreaking Parkinson’s research at La Jolla Institute funded by Michael J. Fox Foundation
LA JOLLA, CA—La Jolla Institute Professor Dr. Alessandro Sette has been awarded a $340,000 grant by The Michael J. Fox
Parkinson’s Disease
The idea that a malfunctioning immune system contributes to Parkinson’s dates back almost 100 years but never gained any traction.